The Traderszone Network

Published in TZ Latest News 30 March, 2017 by The TZ Newswire Staff

Amgen’s Blincyto sBLA Secures FDA Priority Review

Amgen aims to expand the use of Blincyto for more indications of acute lymphoblastic leukemia